Provided herein are pharmaceutically acceptable salts of 3 5 diaminopyrazoles for example pharmaceutically acceptable salts of compounds of Formula (IA) that are useful for modulating regulated in COPD kinase activity and pharmaceutical compositions thereof. Also provided herein are methods of their use for treating preventing or ameliorating one or more symptoms of a RC kinase mediated disorder disease or condition.